Product Information
PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.0277 per EA under NDC 00480229956. Its NADAC has been published 41 times since Sep 17, 2025.
Strength
11.25; 69 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480229956
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA204982On Market Since
5/7/2025
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE has been published 41 times since Sep 17, 2025, and over the history we have for it it has declined 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0277 per EA |
|---|---|
| All-time high | $4.4066 (Oct 15, 2025) |
| All-time low | $3.0277 (Jun 17, 2026) |
| 52-week high | $4.4066 |
| 52-week low | $3.0277 |
| Median price | $3.8701 |
| Average price | $3.7420 |
| Largest weekly change | -13.4% (Feb 18, 2026) |
| Weeks tracked | 41 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Phentermine and topiramate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $3.0277 per EA (NDC 00480229956), effective Jun 24, 2026.
How has the price of PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE has declined 31.3%. It has been tracked across 41 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE?
Since Sep 17, 2025, the NADAC for PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE has ranged from a low of $3.0277 (Jun 17, 2026) to a high of $4.4066 (Oct 15, 2025), with a median of $3.8701 per EA.
Are there cheaper alternatives to PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE?
PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE (NDC 00480229956) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification